2015 Press Releases

Versartis Logo

Versartis’ VRS-317 6-Month Data Published in The Journal of Clinical Endocrinology & Metabolism
December 16, 2015

Afferent Pharmaceuticals Logo

Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to Phase 1 Clinical Trial
December 8, 2015

True North Therapeutics logo

True North Therapeutics Announces $40 Million Series C Financing
December 3, 2015

QPID logo

QPID Health to Showcase New Approach to Quality Reporting at the IHI Forum on Quality Improvement in Healthcare
December 1, 2015

Spiracur logo

Acelity Acquires SNaP® Disposable Negative Pressure Wound Therapy System to Expand Offering in Portable, Non-Powered NPWT Technology
December 1, 2015

iRhythm Logo

iRhythm Technologies Launches New iOS App Enabling Patients to Report Irregular Heartbeat Symptoms for Physician Diagnosis
November 18, 2015

Wave LIfe Sciences logo

WAVE Life Sciences Announces Pricing of Initial Public Offering
November 11, 2015

TigerText Logo

TigerText Closes on $50 Million in Financing to Accelerate Growth; Launches TigerText Anywhere Initiative
November 11, 2015

Reshape medical logo

ReShape Medical, Inc. Builds Momentum with Next Generation Integrated Dual Balloon System at ObesityWeek 2015
November 2, 2015

TigerText Logo

KLAS Report Names TigerText Most Widely Adopted Solution For Secure Messaging
October 28, 2015

Arvinas logo

Arvinas Secures $41.6M Series B Financing – Appoints New Board Members
October 21, 2015

Relypsa Logo

Relypsa announces FDA approval of Veltassa (TM) (Patiromer) for oral suspension for the treatment of Hyperkalemia
October 21, 2015

Dimension logo

Dimension Therapeutics Announces Pricing of Initial Public Offering
October 21, 2015

Unum logo

Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
October 21, 2015

Kitcheck logo

Kit Check Adds Children’s Hospital of Orange County as 200th Hospital Customer
October 21, 2015

QPID logo

QPID Health Announces Groupers for Epic
October 20, 2015

Kyruus logo

U.S. News & World Report and Kyruus Team Up to Help Patients Book Doctor Appointments
October 19, 2015

Edge Therapeutics

Edge Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
October 6, 2015

Versartis Logo

Versartis Presents Confirmatory 18-Month Data From Ongoing Somavaratan Extension Study at Late-Breaker Session at ESPE Annual Meeting
October 1, 2015

Afferent Pharmaceuticals Logo

Afferent Pharmaceuticals Announces Positive Results in Phase 2b Chronic Cough Trial
September 21, 2015

Biopharma_deciphera_press

Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
September 21, 2015

QPID logo

Sharp HealthCare Selects QPID Health for PQRS Compliance
September 21, 2015

Versartis Logo

Versartis Announces Confirmatory 18-Month Data From Ongoing Extension Study of Somavaratan in GHD Children
September 18, 2015

Biopharma_dimension_press

Dimension Therapeutics Announces FDA Fast Track Designation for Lead Candidate DTX101 in Patients with Hemophilia
September 17, 2015

Kyruus logo

Kyruus Raises $25 million to Accelerate Market Adoption of Its Patient Access Platform for Hospital Systems
September 17, 2015

Intarcia logo

Intarcia Presents Results from Two Successful Phase 3 Trials for ITCA 650, Its Investigational Therapy in Type 2 Diabetes, at 51st EASD
September 16, 2015

Versartis Logo

Versartis Initiates Phase 2 Trial (VITAL) of Monthly Somavaratan in Adults With Growth Hormone Deficiency
September 10, 2015

QPID logo

Holyoke Medical Center Selects QPID Health for Quality Initiative
September 2, 2015

MD_reshape_medical_press

ReShape Medical, Inc. Completes $38 Million Series D Financing
August 26, 2015

Edge Therapeutics

Edge Therapeutics Reports Positive Top-Line Phase 1/2 NEWTON Trial Results of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
August 19, 2015

Intarcia logo

Intarcia Announces New Top-Line Phase 3 Results for Investigational Therapy ITCA 650 in Type 2 Diabetes: Freedom-2 Comparative Trial Demonstrates Superior & Sustained Glucose Control and Weight Reduction vs Januvia Over 52 Weeks
August 18, 2015

Wave LIfe Sciences logo

WAVE Life Sciences Raises $66 Million in Series B Financing
August 18, 2015

QPID logo

QPID Health to Deploy at Providence Health & Services
August 11, 2015

Relypsa Logo

Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States
August 10, 2015

IC_truveris_press

New App Helps Consumers Find More Ways to Save on Prescription Drugs
August 5, 2015

MD_reshape_medical_press

FDA Approves The ReShape™ Integrated Dual Balloon System, a First-Of-Its-Kind Non-Surgical Weight Loss Procedure for People with Mild to Moderate Obesity
July 28, 2015

Chimerix logo

Chimerix Announces Positive Topline Results From Brincidofovir Pivotal Study in Animal Model for Smallpox
July 23, 2015

QPID logo

QPID Health sequences the “digital DNA” in your health record
July 22, 2015

Afferent Pharmaceuticals Logo

Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing
July 8, 2015

Bio_research_acd_press

Advanced Cell Diagnostics Completes $22 Million Series C Equity Financing
June 18, 2015

Biopharma_tioga_press

Tioga Pharmaceuticals Announces Initiation of Phase 2 Clinical Study of Asimadoline in Patients with Pruritus Associated with Atopic Dermatitis
June 11, 2015

Biopharma_unum_press

Unum Therapeutics Announces $65 Million Series B Financing Round
June 11, 2015

Oxford Immunotec

Oxford Immunotec Announces First Patient Enrolled in REACT Trial for T-SPOT.CMV
June 11, 2015

Biopharma_intarcia_press

Intarcia’s Kurt Graves Named an EY Entrepreneur Of The Year® 2015
June 5, 2015

Vaxinnate

VaxInnate Advances Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, into Phase 2 Study
June 3, 2015

Spiracur logo

Spiracur Expands Global Reach with the Release of New International Clinical Data and the Introduction of the SNaP Plus Therapy System
June 2, 2015

Edge Therapeutics

Edge Therapeutics Completes Enrollment in Phase 1/2 NEWTON Study of EG-1962 for Patients with Ruptured Brain Aneurysm
May 28, 2015

Kitcheck logo

Kit Check Tracks Five Million Hospital Medications with RFID and Cloud Software Solution
May 28, 2015

Oxford Immunotec

Oxford Immunotec Announces CE Mark Approval for T-SPOT.CMV Test
April 27, 2015

Biopharma_intarcia_press

Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing with Equity Conversion Option at $5.5 Billion Valuation
April 27, 2015

Neuronetics Logo

Neuronetics Closes $34 Million in Series F Financing with GE Ventures and Current Investors
April 27, 2015

IC_irhythm_press

Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring
April 21, 2015

Biopharma_dimension_press

Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing
April 21, 2015

IC_tigertext_press

TigerText Introduces First Secure Enterprise Messaging App for the Apple Watch
April 14, 2015

Biopharma_versartis_press

Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency
April 13, 2015

Karyopharm Logo

Karyopharm Granted U.S. Composition-of-Matter Patent for Selinexor (KPT-330)
April 13, 2015

Edge Therapeutics

Edge Therapeutics Raises $72.5 Million Through Successive Series C-1 and C-2 Financings
April 9, 2015

IC_tigertext_press

Group Message Confirmations Are Here! (TigerText)
April 9, 2015

Kitcheck logo

Amerinet Offers Kit Check to 3,000 Member Hospitals
April 7, 2015

Oxford Immunotec

Oxford Immunotec Announces Availability of the T-SPOT.CMV Test in the United States
March 31, 2015

MD_cardiokinetix_press

CardioKinetix Announces Excellent Results of Chinese Trial Evaluating Parachute Heart Failure Device
March 24, 2015

Biopharma_intarcia_press

Intarcia and Numab Sign Multi-Asset Collaboration to Develop Once-Yearly Therapies in Diabetes, Obesity, and Autoimmune Indications
March 19, 2015

IC_truveris_press

Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefit Costs
March 17, 2015

Biopharma_relypsa_press

Relypsa Announces Phase 2 Data Showing Efficacy of Patiromer FOS in Heart Failure Patients With Chronic Kidney Disease at ACC Scientific Session
March 14, 2015

IC_tigertext_press

TigerText Launches TigerConnect Secure Messaging Platform
March 3, 2015

Vaxinnate

VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines
February 17, 2015

Oxford Immunotec

Oxford Immunotec Global PLC Announces Pricing of Underwritten Offering of Ordinary Shares
January 30, 2015

Biopharma_versartis_press

Versartis Announces Pricing of Follow-On Offering
January 21, 2015

Kitcheck logo

Kit Check Raises $12 Million Series B
January 12, 2015

Biopharma_chimerix_press

Chimerix Receives Notice of Allowance for Brincidofovir Composition of Matter Patent Extending Exclusivity to 2034
January 12, 2015

Convergence Logo

Biogen Idec to Expand Neuropathic Pain Portfolio with the Acquisition of Convergence Pharmaceuticals
January 11, 2015

Oxford Immunotec

Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test
January 6, 2015

Relypsa

Relypsa Announces Assignment of October 21, 2015 PDUFA Date for New Drug Application for Patiromer for Oral Suspension
January 5, 2015

Versartis

Versartis Announces Positive 12 Month Data for VRS-317 from Ongoing Extension Study
January 5, 2015